Progress in the prevention and control of schistosomiasis and soil-transmitted helminthiasis

Giornale Italiano di Medicina Tropicale

Volumn 7, Issue 1-4, 2002, Pages 11-20

  Albonico, Marco ^a,e   Engels, D ^b   Montresor, A ^b   Cromptons, D W T ^c   De Silva, N R ^d   Savioli, L ^b  

^a Ivo de Carneri Foundation   (Italy)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF KELANIYA   (Sri Lanka)

^e NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; IVERMECTIN; LEVAMISOLE; MEBENDAZOLE; OXANTEL; PRAZIQUANTEL; PYRANTEL;

DISEASE CONTROL; HELMINTHIASIS; HIGH RISK POPULATION; HUMAN; LACTATION; MORBIDITY; NEMATODE; PARASITE TRANSMISSION; PREGNANCY; REVIEW; SCHISTOSOMIASIS; SOIL; WORLD HEALTH ORGANIZATION;

EID: 0141716839     PISSN: 03943445     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. ALBONICO M., BICKLE Q., HAJI H.J., RAMSAN M., KHATIB J.K., SAVIOLI L., TAYLOR M. (2002). Evaluation of the efficacy of pyrantel-oxantel for the treatment of soil-transmitted nematode infections. Transactions of The Royal Society of Tropical Medicine and Hygiene 96: 685-690.
2. ALBONICO M., BICKLE Q., RAMSAN M., MONTRESOR A., SAVIOLI L., TAYLOR M. (2003). Efficacy of mebendazole and levamisole alone or in combination for the treatment of soil-transmitted nematode infections following repeated targeted mebendazole treatment in Zanzibar. Bulletin of the World Health Organization (in press).
3. ALBONICO M., SAVIOLI, L. (1997). Hookworm infection and disease: advances for control. Annali dell'Istituto Superiore di Sanità, 33(4): 567-579.
4. APPLETON C., MBAYE A. (2001). Praziquantel quality, dosages and markers of resistance. Trends in Parasitology, 17: 356-357.
5. ATUKORALA T.M.S., DE SILVA L.D.R., DECHERING W.H.J.C., DANNENAEIKE T.S., PERERA R.S. (1994). Evaluation and effectiveness of iron-folate supplementation and anthelminthic therapy against anemia in pregnancy - a study in the plantation sector of Sri Lanka. American Journal of Clinical Nutrition, 60: 286-292.
6. BELIZARIO V.Y., DE LEON W.U., AMARILLO M.E., DE LOS REYES A.E., BUGAYONG M.G., MACATANGAY B.J.C. (2003). A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp. Bulletin of the World Health Organization, 81: 35-42.
7. BUNDY D.A.P., COOPER E.S. (1989). Trichuris and trichuriasis in humans. Advances in Parasitology, 28: 107-173.
8. CHAN M.S. (1997). The global burden of intestinal nematode infections - Fifty years on. Parasitology Today, 13: 438-443.
9. CIOLI D., PICA-MATTOCCIA L., ARCHER S. (1993). Drug resistance in schistosomes. Parasitology Today, 9: 162-166.
10. CROMPTON D.W.T., WHITEHEAD R.R. (1993). Hookworm infections and human iron metabolism. Parasitology, 107: S 137-S 145.
11. CROMPTON D.W.T. (1999). How much human helminthiasis is there in the world? The Journal of Parasitology, 3: 397-403.
12. CROMPTON D.W.T. (2000). The public health importance of hookworm disease. Parasitology, 121: S39-S50.
13. CROMPTON D.W.T. (2001). Ascaris and ascariasis. Advances in Parasitology, 48: 285-375.
14. CROMPTON D.W.T., NESHEIM M.C. (2002). Nutritional impact of intestinal helminthiasis during the human life cycle. Annual Review of Nutrition, 22: 35-59.
15. DE SILVA N., GUYATT H., BUNDY D. (1997). Morbidity and mortality due to Ascaris- induced intestinal obstruction. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91: 31-36.
16. DE SILVA N.R. SIRISENA J.L., GUNASEKERA D.P., ISMAIL M.M., DE SILVA H.J. (1999). Effect of mebendazole therapy in pregnancy on birth outcome. Lancet, 353:1145-1149.
17. DOENHOFF M., KIMANI G., CIOLI D. (2000). Praziquantel and the control of schistosomiasis. Parasitology Today, 16: 364-366.
18. DOENHOFF M.J., KUSEL J.R., COLES G.C., CIOLI D. (2002). Resistance of Schistosoma mansoni to praziquantel: is there a problem? Transactions of the Royal Society of Tropical Medicine and Hygiene, 96: 465-469.
19. DRAKE L., MAIER C., JUKES M., PATRIKIOS A., BUNDY D. (2002). School-age children: their nutrition and health. SCN News, 25: 4-30.
20. FRENZEL K., GRIGULL L., ODONGO-AGYNIA E., NDUGWA C.M., LORONI-LAKWO T., SCHWEIGMANN U., VESTER U., SPANNBRUCKER N., DOEHRING E. (1999). Evidence for a long-term effect of a single dose of praziquantel on Schistosomoa mansoni-induced hepatosplenic lesions in Northern Uganda. American Journal of Tropical Medicine and Hygiene, 60(6): 927-931.
21. GEERTS S., GRYSEELS B. (2000). Drug resistance in human helminths: current situation and lessons form livestock. Clinical Microbiology Reviews, 13: 207-222
22. GEERTS S., GRYSEELS B. (2001). Anthelminthic resistance in human helminths: a review. Tropical Medicine and International Health, 6(11): 915-921.
23. HATZ C.F., VENNERVALD B.J., NKULILA T., VOUNATSOU P., KOMBE Y., MAYOMBANA C., MSHINDA H., TANNER M. (1998). Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among schoolchildren in Southeastern Tanzania. American Journal of Tropical Medicine and Hygiene, 59(5): 775-781.
24. LIANG Y.S., COLES G.C., DOENHOFF M.J., SOUTHGATE V.R. (2001). In vitro resposes of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel. International Journal for Parasitology, 31: 1227-1235.
25. MIGUEL E., KREMER M. (2001). Worms: Education and Health Externalities in Kenya Cambridge, MA: National Bureau of Economic Research, Working Paper No. w8481-http://www.nber.org/papers/W8481
26. MONTRESOR A. ENGELS D., CHITSULO L., BUNDY D.A., BROOKER S., SAVIOLI L. (2001). Development and validation of a "tablet pole" for the administration of praziquantel in sub-Saharan Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95: 1-3.
27. MONTRESOR A., RAMSAN M., CHWAYA H.M., AMEIR H., FOUM A., ALBONICO M., GYORKOS T.W., SAVIOLI L. (2000). Extending anthelminthic coverage to non-enrolled school-age children using a simple and low-cost method. Tropical Medicine and International Health, 6: 535-537.
28. MONTRESOR A., STOLTZFUS R.J., ALBONICO M., TIELSCH J.M., RICE A.L., CHWAYA H.M., SAVIOLI L. (2002). Is the exclusion of children under 24 months from anthelminthic treatment justifiable? Transactions of The Royal Society of Tropical Medicine and Hygiene, 96(2):197-9.
29. NOKES C., GRANTHAM MC-GREGOR S.M., SAWYER A.W., ROBINSON B.A., BUNDY D.A.P. (1992). Moderate to heavy infections of Trichuris trichiura affect cognitive function in Jamaican schoolchildren. Parasitology, 104: 1-9.
30. RENGANATHAN E., CIOLI D. (1998). An International Initiative on Praziquantel Use. Parasitology Today, 14: 390-391.
31. ROOS H.M., KWA M.S.G., GRANT W.N. (1995). New genetic and practical implications of selection for anthelmintic resistance in parasitic nematodes. Parasitology Today 11: 148-150.
32. SAVIOLI L., STANSFIELD S., BUNDY D.A., MITCHELL A., BHATIA R., ENGELS D., MONTRESOR A., NEIRA M., SHEIN A.M. (2002) Schistosomiasis and soil-transmitted helminth infections: forging control efforts. Transactions of the Royal Society of Tropical Medicine and Hygiene, 96(6):577-9.
33. SAVIOLI L., RENGANATHAN E., MONTRESOR A., DAVIS A., BEHBEHANI K. (1997). Control of Schistosomiasis - A global picture. Parasitology Today 13(11): 444-448.
34. STEPHENSON L. (1993). The impact of schistosomiasis on human nutrition. Parasitology, 107: S107-S123.
35. STOLTZFUS R., DREYFUSS M.L., CHWAYA H.M., ALBONICO M. (1997). Hookworm control as a strategy to prevent iron deficiency. Nutrition Reviews, 55(6): 223-232.
36. STOLTZFUS R.J., ALBONICO M., CHWAYA H.M., TIELSCH J.M., SCHULZE K.J., SAVIOLI L. (1998). Effects of the Zanzibar school-based deworming program on iron status of children. American Journal of Clinical Nutrition, 68: 179-186.
37. STOLTZFUS R.J., KVALSVIG J.D., CHWAYA H.M., MONTRESOR A., ALBONICO M., TIELSCH J.M., SAVIOLI L., POLLIT E. (2001). Effects of iron supplementation and anthelminthic treatment on motor and language development of preschool children in Zanzibar: double blind placebo controlled study. British Medical Journal, 323: 1-8.
38. SULAIMAN S.M., TRAORÉ M., ENGELS D., HAGAN P., CIOLI D. (2001). Counterfeit praziquantel. The Lancet, 358: 666-667 (correspondence).
39. TALAAT M., EVANS D.B. (2000). The costs and coverage of a strategy to control schistosomiasis morbidity in non-enrolled school-age children in Egypt. Transactions of the Royal Society for Tropical Medicine and Hygiene, 94: 449-54.
40. TORLESSE H., HODGES M. (2000). Anthelminthic treatment and haemoglobin concentrations during pregnancy. Lancet 356(9235):1083.
41. VAN DER WERF M.J., DE VLAS S.J., BROOKER S., LOOMAN C.W.N., NAGELKERKE N.J.D., HABBEMA J.D.F., ENGELS D. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Tropica, 86: 125-139.
42. WORLD DEVELOPMENT REPORT (1993). Investing in Health. New York, Oxford University Press.
43. WORLD HEALTH ORGANIZATION (1996). Report of the WHO Informal Consultation on Hookworm Infection and Anaemia in Girls and Women. WHO/CTD/SIP/96.1, Geneva.
44. WORLD HEALTH ORGANIZATION (1998). Report of the WHO Informal Consultation on monitoring of drug efficacy in the control of schistosomiasis and intestinal nematodes. Geneva, 8-10 July 1998, WHO/CDS/CPC/SIP/99.1, Geneva.
45. WORLD HEALTH ORGANIZATION (1999). World Health Report. Making a difference. Geneva.
46. WORLD HEALTH ORGANIZATION (2000). The use of essential drugs. Technical Report Series, No. 895. Geneva.
47. WORLD HEALTH ORGANIZATION (2001). Report of the World Health Assembly. Resolution N. 54.19. Geneva.
48. WORLD HEALTH ORGANIZATION (2002). Report of the WHO Informal Consultation on the use of praziquentel during pregnancy/lactation and albendazole/mebendazole in children under 24 months. Division of Control of Communicable Diseases, Geneva (in press).